Disease associated variation - GWASdb |
Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
16 | 84785672 | rs4783057 | G | A | rs4783057 | 4.30E-04 | GEMCITABINE|CYTARABINE | MANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINE | Response to cytidine analogues (gemcitabine) | HPOID:0002664 | DOID:162 | G,A | intron | GWASdb_drug |
16 | 84786250 | rs6564074 | C | A | rs6564074 | 1.48E-04 | GEMCITABINE|CYTARABINE | MANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINE | Response to cytidine analogues (gemcitabine) | HPOID:0002664 | DOID:162 | A | intron | GWASdb_drug |
16 | 84796402 | rs7205632 | A | T | rs7205632 | 4.88E-04 | GEMCITABINE|CYTARABINE | MANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINE | Response to cytidine analogues (gemcitabine) | HPOID:0002664 | DOID:162 | T | intron | GWASdb_drug |
16 | 84801751 | rs2641688 | G | A | rs2641688 | 6.53E-04 | GEMCITABINE|CYTARABINE | MANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINE | Response to cytidine analogues (gemcitabine) | HPOID:0002664 | DOID:162 | G | intron | GWASdb_drug |
16 | 84741149 | rs8045120 | G | T | rs8045120 | 1.30E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | G | intron | GWASdb_trait |
16 | 84741343 | rs3764286 | C | T | rs3764286 | 8.79E-04 | | | Parkinson's disease | HPOID:0001300 | DOID:14330 | A | intron | GWASdb_trait |
16 | 84750595 | rs1862794 | C | T | rs1862794 | 8.34E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | T | intron | GWASdb_trait |
16 | 84750595 | rs1862794 | C | T | rs1862794 | 2.87E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | T | intron | GWASdb_trait |
16 | 84750816 | rs41422347 | T | C | rs41422347 | 1.19E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | A | intron | GWASdb_trait |
16 | 84754898 | rs12149617 | G | A | rs12149617 | 1.48E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | A | intron | GWASdb_trait |
16 | 84754898 | rs12149617 | G | A | rs12149617 | 3.91E-04 | | | Coronary Artery Disease | HPOID:0001677 | DOID:3393 | A | intron | GWASdb_trait |
16 | 84769024 | rs41386649 | C | T | rs41386649 | 2.64E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | C | intron | GWASdb_trait |
16 | 84771176 | rs17763304 | C | T | rs17763304 | 7.13E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | C | intron | GWASdb_trait |
16 | 84771176 | rs17763304 | C | T | rs17763304 | 3.42E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | C | intron | GWASdb_trait |
16 | 84771176 | rs17763304 | C | T | rs17763304 | 7.82E-04 | | | Coronary Artery Disease | HPOID:0001677 | DOID:3393 | C | intron | GWASdb_trait |
16 | 84774120 | rs4510001 | T | C | rs4510001 | 5.71E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | G | intron | GWASdb_trait |
16 | 84774120 | rs4510001 | T | C | rs4510001 | 1.70E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | G | intron | GWASdb_trait |
16 | 84774436 | rs744839 | C | T | rs744839 | 9.72E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | C | intron | GWASdb_trait |
16 | 84780907 | rs11149680 | C | T | rs11149680 | 0.0003 | | | Normoxic and mild-hypoxic adaptation in populations residing at low and moderate altitudes | HPOID:0002795 | DOID:2841|DOID:3083 | C | intron | GWASdb_trait |
16 | 84781101 | rs8051512 | C | G | rs8051512 | 2.31E-04 | | | Parkinson's disease | HPOID:0001300 | DOID:14330 | G | intron | GWASdb_trait |
16 | 84783658 | rs16974538 | T | G | rs16974538 | 3.10E-05 | | | Cognitive performance | HPOID:0100543 | DOID:1561 | T | intron | GWASdb_trait |
16 | 84785378 | rs17831494 | G | A | rs17831494 | 8.06E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | A,G | intron | GWASdb_trait |
16 | 84785378 | rs17831494 | G | A | rs17831494 | 9.03E-05 | | | Multiple complex diseases | HPOID:0000118 | NA | A,G | intron | GWASdb_trait |
16 | 84785672 | rs4783057 | G | A | rs4783057 | 3.74E-04 | | | Response to taxane treatment (placlitaxel) | HPOID:0100526 | DOID:1324 | G,A | intron | GWASdb_trait |
16 | 84785672 | rs4783057 | G | A | rs4783057 | 4.30E-04 | | | Response to cytidine analogues (gemcitabine) | HPOID:0002664 | DOID:162 | G,A | intron | GWASdb_trait |
16 | 84786250 | rs6564074 | C | A | rs6564074 | 1.93E-04 | | | Response to taxane treatment (placlitaxel) | HPOID:0100526 | DOID:1324 | A | intron | GWASdb_trait |
16 | 84786250 | rs6564074 | C | A | rs6564074 | 1.48E-04 | | | Response to cytidine analogues (gemcitabine) | HPOID:0002664 | DOID:162 | A | intron | GWASdb_trait |
16 | 84786855 | rs7186789 | T | G | rs7186789 | 6.13E-04 | | | Depression (quantitative trait) | HPOID:0000716 | DOID:1596 | T | intron | GWASdb_trait |
16 | 84796402 | rs7205632 | A | T | rs7205632 | 5.85E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | T | intron | GWASdb_trait |
16 | 84796402 | rs7205632 | A | T | rs7205632 | 4.14E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | T | intron | GWASdb_trait |
16 | 84796402 | rs7205632 | A | T | rs7205632 | 4.88E-04 | | | Response to cytidine analogues (gemcitabine) | HPOID:0002664 | DOID:162 | T | intron | GWASdb_trait |
16 | 84796603 | rs12932018 | A | G | rs12932018 | 6.00E-06 | | | Response to mTOR inhibitor (everolimus) | HPOID:0002665|HPOID:0005584|HPOID:0003002|HPOID:0100526|HPOID:0012114|HPOID:0100843 | DOID:4450|DOID:1612|DOID:3908|DOID:2871|DOID:3068|DOID:0050746 | A | cds-synon | GWASdb_trait |
16 | 84801751 | rs2641688 | G | A | rs2641688 | 6.53E-04 | | | Response to cytidine analogues (gemcitabine) | HPOID:0002664 | DOID:162 | G | intron | GWASdb_trait |